Skip to NavigationSkip to content

News

Array Biopharma has revealed new data on its combination of Braftovi, Mektovi, and Erbitux, showing that it met both of its primary endpoints in the...
California biotech Amgen has agreed to buy Danish biopharmaceutical company Nuevolution AB for 1.61 billion Swedish crowns ($166.8 million).
Takeda has announced that Japan’s drug regulator, the Ministry of Health, Labour and Welfare (MHLW), has approved Entyvio (vedolizumab) in the...
MSD has agreed to acquire all outstanding shares in Peloton Therapeutics in a deal worth up to $2.1 billion.
Children wait six and half years longer than adults to access new cancer drugs, according to a study from Dana-Farber/Boston Children's Cancer and...
New research has been published on the efficacy of esketamine in the treatment of depression, following its approval from the FDA in the US in...
GP consultations should be five minutes longer, with 10 minute doctors’ appointments being a ‘thing of the past,’ according to a report from the...
Researchers at Imperial College London (ICL) and Johannes Gutenberg University Mainz have shown that xenon prevents early death and long-term...
MSD has made it known that its cancer immunotherapy Keytruda (pembrolizumab) failed to meet its primary endpoint in a Phase 3 study evaluating its...
An artificial intelligence (AI) is better than specialist doctors at diagnosing lung cancer, according to a study from researchers at Google and...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches